Endothelial cells cultured from human brain microvessels produce complement proteins factor H, factor B, C1 inhibitor, and C4

Immunobiology

Volumn 199, Issue 1, 1998, Pages 5-13

  Vastag, Monika ^a   Skopál, Judit ^a   Kramer, Judit ^a   Kolev, Krasimir ^a   Vokó, Zoltán ^a   Csonka, Éva ^a   Machovich, Raymund ^a   Nagy, Zoltán ^a,b  

^a SEMMELWEIS UNIVERSITY OF MEDICINE   (Hungary)

^b National Stroke Centre   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

ALTERNATIVE COMPLEMENT PATHWAY C3 C5 CONVERTASE; COMPLEMENT COMPONENT C1S INHIBITOR; COMPLEMENT COMPONENT C4; COMPLEMENT FACTOR H; GAMMA INTERFERON; MINIPLASMIN; PLASMIN; SERINE PROTEINASE; UNCLASSIFIED DRUG;

ARTICLE; BRAIN BLOOD VESSEL; BRAIN CELL; BRAIN INJURY; BRAIN ISCHEMIA; CELL CULTURE; COMPLEMENT SYSTEM; CONTROLLED STUDY; ENCEPHALITIS; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; INFLAMMATION; MICROVASCULATURE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REPERFUSION;

EID: 0031927164     PISSN: 01712985     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0171-2985(98)80059-4     Document Type: Article

References (39)

1. NAGY, Z. 1990. Blood-brain barrier and the cerebral endothelium. Pathophysiology of the blood-brain barrier. Long term consequences of barrier dysfunction for the brain. Eds. JOHANSSON, B. B., OWMAN, C. and H. WIDNER, Elsevier Science Publishers B.V., Amsterdam, 11-29 pp.
2. BRIGHTMAN, M. W., and J. H. TAO-CHENG. 1993. Tight junctions of brain endothelium and epithelium. The blood-brain barrier. Cellular and molecular biology. Ed. PARDRIDGE, W. M., Raven Press, New York, 107-127 pp.
3. BRADBURY, M. W. 1989. Transport across the blood-brain barrier. Implications of the blood-brain barrier and its manipulation. Vol. I. Basic science aspects. Ed. NEUWELT, E. A., Plenum Medical Book Company, New York and London, 85-113 pp.
4. DEL ZOPPO, G. J. 1994. Microvascular changes during cerebral ischaemia and reperfusion. Cerebrovasc. Brain Metab. Rev. 6: 47-96.
5. GUMERLOCK, M. K. 1989. Cerebrovascular disease and the blood-brain barrier. Implications of the blood-brain barrier and its manipulation. Vol. 2. Clinical aspects. Ed. NEUWELT, E. A., Plenum Medical Book Company, New York and London, 495-565 pp.
6. LINDSBERG, P. J., J. ÖHMAN, and T. LEHTO. 1996. Complement activation in the central nervous system following blood-brain barier damage in man. Ann. Neurol. 40: 587-496.
7. COLTEN, H. R. 1976. Biosynthesis of complement. Adv. Immunol. 22: 67-118.
8. KATZ, Y., M. GUTTERMAN, and E. LAHAT. 1993. Regulation of complement proteins in Hep2 cells. Clin. Immunol. Immunopathol. 67: 117-123.
9. PERISUTTI, S., and F. TEDESCO. Effect of cytokines on the secretion of the fifth and eight complement components by HepG2 cells. Int. J. Clin. Lab. Res. 24: 45-48.
10. NAUGHTON, M. A., M. BOTTO, M. J. CARTER, G. J. ALEXANDER, I. M. GOLDMAN, and M. J. WALPORT. 1996. Extrahepatic secreted complement C3 contributes to circulating C3 levels in humans. J. Immunol. 156: 3051-3056.
11. STRUNK, R. C., J. A. FLEISCHER, Y. KATZ, and F. S. COLE. 1994. Developmentally regulated effects of lipopolysaccharide on biosynthesis of the third component of complement and factor B in human fibroblasts and monocytes. Immunology 82: 314-320.
12. KATZ, Y., and R. C. STRUNK. 1989. Synthesis and regulation of C1 inhibitor in human skin fibroblasts. J. immunol. 142. 2041-2045.
13. SMITH, M. D., D. H. CRIBBS, A. J. TENNER, W. R. SHANKLE, M. DICK, J. P. KESSLAK, and C. W. COTMAN. 1994. Decreased levels of C1q in cerebrospinal fluid in living Alzheimer patient correlate with disease state. Neurobiol. Aging 15: 609-614.
14. MCGEER, P. L., T. KAWAMATA, D. G. WALKER, H. AKIYAMA, I. TOOYAMA, and E. G. MCGEER. 1993. Microglia in degenerative neurological disease. Glia 7: 84-92.
15. CACVAVELOS, R., X. A. ALVAREZ, L. FERNANDEZ-NOVOA, A. FRANCO, R. MANGUES, A. PELLICER, and T. NISHIMURA. 1994. Brain interleukin-1 beta in Alzheimer disease and vascular dementia. Methods. Find. Exp. Clin. Pharmacol. 16: 141-151.
16. ASIEN, P. S., and K. L. DAVIES. 1994. Inflammatory mechanisms in Alzheimer's disease: Implications for therapy. Am. J. Psychiatry 151: 1105-1113.
17. BARNUM, S. R. 1995. Complement biosynthesis in the central nervous system. Crit. Rev. Oral. Biol. Med. 6. 132-146.
18. LAPPIN, D. F., D. GUC, A. HILL, T. MCSHANE, and K. WHALEY. 1992. Effect of interferon-gamma on complement gene expression in different cell types. Biochem. J. 281: 437-442.
19. CADENA, R. A. D., I. T. WACHTFOGEL, and R. W. COLMAN. 1994. Contact activation pathway: Inflammation and coagulation. In: Hemostasis and thrombosis: basic principles and clinical practice. Eds. COLMAN, R. W., HIRSH, J., MARDER, V. J., and SALZMAN, E. W., Lippincott, Philadephia, 219-240 pp.
20. SUNDSMO, J. S., and D. S. FAIR. 1983. Relationships among the complement, kinin, coagulation and fibrinolytic system in the inflammatory reaction. Clin. Physiol. Biochem. 1: 225-284.
21. MOROZ, L. A., S. WING, and F. LIOTÉ. 1986. Mini-plasminogen-like fragments of plasminogen in synovial fluid in acute inflammatory arthritis. Thromb. Res. 43: 417-424.
22. KORDICH, L. C., V. P. PORTERIE, O. LAGO, G. E. BERGONZELLI, B. SASSETTI, and J. C. SANCHEZ AVALOS. 1987. Mini-plasminogen like molecule in septic patients. Thromb. Res. 47: 553-560.
23. MACHOVICH, R., and W. G. OWEN. 1989. An elastase-dependent pathway of plasminogen activation. Biochemistry 28: 4517-4522.
24. MACHOVICH, R., and W. G. OWEN. 1990. The elastase-mediated pathway of fibrinolysis. Blood Coag. Fibrinol. 1: 79-80.
25. VASTAG, M., and Z. NAGY. 1997. Methods of isolation and culture of human brain microvessel endothelium. Drug transport across the blood-brain barrier: New experimental strategy. Eds. DE BOER, A. B. G., and SUTANTO, W., Harwood Academic Publishers GmbH, The Netherlands, 109-113 pp.
26. NAGY, Z., K. KOLEV, É., CSONKA, M. PÉK, and R. MACHOVICH. 1995. Contraction of human brain endothelial cells induced by thrombogenic and fibrinolytic factors. An in vitro cell culture model. Stroke 26: 265-270.
27. VOYTA, J. C., D. P. VIA, C. E. BUTTERFIELD, and B. R. ZETTER. 1984. Identification and isolation of endothelial cells based on their increased uptake of acetylated-low density lipoprotein. J. Cell Biol. 99: 2034-2040.
28. KOLEV, K., E. KOMOROWICZ, and R. MACHOVICH. 1994. Heparin modulation of the fibrinolytic activity of plasmin, miniplasmin and neutrophil leukocyte elastase in the presence of plasma protease inhibitors. Blood Coag. Fibrinol. 5: 905-911.
29. CUZICK, J. 1985. A Wilcoxon-type test for trend. Stat. Med. 4: 87-90.
30. NAGY, Z., M. VASTAG, J. SKOPÁL, K. KOLEV, R. MACHOVICH, J. KRAMER, I. KARÁDI, and M. TÓTH. 1996. Human brain microvessel endothelial cell culture as a model system to study vascular factors of ischaemic brain. Keio. J. Med. 45: 200-206.
31. STRAUSS, M. L., and M. MALLATT. 1987. Primary cultures of murine astrocytes produce C3 and factor B, two components of the alternative pathway of complement activation. J. Immunol. 139: 2361-2366.
32. SCHMAIER, A. H., S. C. MURRAY, G. D. HEDA, A. FARBER, A. KUO, M. MCCRAE, and D. B. CINES. 1989. Synthesis and expression of C1 inhibitor by human umbilical vein endothelial cells. J. Biol. Chem. 264: 18173-18179.
33. KATZ, Y., and R. C. STRUNK. 1988. Synovial fibroblast-like cells synthesize seven proteins of the complement system. Arthritis Rheum. 31: 1365-1370.
34. KAPLAN, A. P., M. SILVERBERG, J. T. DUNN, and B. GHEBREHIWET. 1982. Interaction of the clotting, kinin-forming, complement, and fibrinolytic pathways in inflammation. Ann. N.Y. Acad. Sci. 371: 25-38.
35. HESSING, M. 1991. The interaction between complement component C4b-binding protein and the vitamin K-dependent protein S forms a link between blood coagulation and the complement system. Biochem. J. 277: 581-592.
36. RATNOFF, O. D., and G. B. NAFF. 1961. The conversion of C1s to C1 esterase by plasmin and trypsin. J. Exp. Med. 125. 337-358.
37. ROSSI, V., C. GABORIAUD, M. LACROIX, J. ULRICH, J. C. FONTECILLA-CAMPS, J. GAGUON, and G. J. ARLAUD. 1995. Structure of the catalytic region of human complement protease C1s: study by chemical cross-linking and three-dimensional homology modeling. Biochemistry. 34: 731-7321.
38. HARPEL, P. C. 1970. C1 inactivator inhibition by plasmin. J. Clin. Invest. 49: 568-575.
39. SCHREIBER, A. D., A. P. KAPLAN, and K. F. AUSTEN. 1973. Inhibition by C1 INH of Hageman factor fragment activation of coagulation, fibrinolysis and kinin-generation. J. Clin. Invest. 52: 1394-1401.